The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

On Saturday, Gilead Sciences, Inc. (NASDAQ:GILD) and Merck & Co. Inc. (NYSE:MRK) revealed new results from a Phase 2 clinical ...

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and ...

New data from the PURPOSE 2 trial continue to show the efficacy of lenacapavir in HIV prevention in individuals who have sex ...

The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...

Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without ...

The World Council of Churches has newly published a discussion document: Good News about HIV Treatment, Cure, and Healing: ...

In the complex landscape of chronic health conditions, living with HIV while recovering from a stroke presents a unique set ...

HIV activist Solly Nduku was recently elected to the top civil society position at the South African National Aids Council.

People with HIV are more likely to have severe premenstrual syndrome (PMS) symptoms than others, such as: In the United States, about 2% of transgender people make up new HIV diagnoses.

New report shows an increase in HIV cases in Alberta. Experts tell Hiba Kamal-Choufi there should be a holistic approach to ...